Johnson & Johnson On ‘Single-Dose’ COVID-19 Vaccine Data
Johnson & Johnson’s 2021 profit forecast goes way higher than “Wall Street estimates”.
Johnson & Johnson’s 2021 profit forecast goes way higher than “Wall Street estimates”.
A health worker in California tested positive for COVID-19 following a week of vaccination.
Has the winning year for ‘corporate stay-at-homes’ come to an end?
Pfizer is expecting to get its “manufacturing data ready” for submitting to the regulators by late November.
31% board of directors at UPS are female representatives.
Following a “natural evolution” and the market strength, Pfizer has announced a breakup into three units.
‘New tax rate’ of Pfizer exceeds investors’ expectations and pulls down its shares.
Steglatro will be treating type II diabetes orally.
As per Pfizer’s Chief Executive, the core reason for this divestiture is to provide a better return for shareholder’s money: its consumer healthcare is worth more outside the group than within.
Two different corporate coalitions are formed; one supports Republican House’s tax proposal while the other opposes the same and rallies for Congress.
The “average analyst” forecast of Pfizer’s earnings were missed by one percent per share.
Pfizer continues to expand its research field in cancer and antibiotics.
The acquisition of Bamboo can boost Pfizer’s gene therapy investment agenda.
An announcement made by Allergan regarding a few discussions was confirmed by Pfizer.